ZFP287 Inhibitors
ZFP287 inhibitors such as chemicals like 5-Azacytidine and Trichostatin A can interfere with gene expression and chromatin modification, which may alter the transcriptional regulation involving ZFP287. Proteasome inhibitors such as MG132 and Bortezomib can prevent the degradation of proteins, potentially increasing the cellular levels of ZFP287 if it is subject to proteasomal degradation. Inhibitors of signaling pathways, such as LY294002, PD98059, SB203580, SP600125, and Wortmannin, target various kinases that are central to cell survival, growth, differentiation, and stress responses. By modulating these pathways, the activity or context in which ZFP287 operates may be altered.
In addition, Y-27632 affects the Rho kinase signaling that can modulate the cytoskeleton, potentially affecting cellular processes that ZFP287 might influence. 2-Deoxy-D-glucose disrupts glycolysis, altering the metabolic state of the cell, which can have far-reaching effects on cellular function and potentially impact ZFP287. Lastly, Rapamycin targets mTOR signaling, which is fundamental to cell growth and proliferation, and could, therefore, affect the biological processes in which ZFP287 is involved.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that can incorporate into DNA and RNA, potentially affecting the gene expression regulation in which ZFP287 may be involved. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An inhibitor of histone deacetylase (HDAC) that can alter chromatin structure and gene expression, possibly influencing ZFP287 function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can affect protein degradation pathways, potentially impacting the stability and levels of ZFP287. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can alter signaling pathways, potentially affecting ZFP287's role in these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that can disrupt MAPK/ERK signaling, which might influence ZFP287 activity if it is related to this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can modify inflammatory signaling pathways, potentially impacting the function of ZFP287. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK that can affect apoptosis and other cellular processes, possibly affecting ZFP287-associated pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that can influence cytoskeletal organization and cellular mechanics, potentially impacting ZFP287's function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glycolysis inhibitor that can alter energy metabolism, potentially affecting the cellular context in which ZFP287 operates. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect cell growth and proliferation, potentially impacting processes where ZFP287 is involved. | ||||||